nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Framycetin—CXCR4—breast cancer	0.0183	1	CrCbGaD
Tobramycin—Agranulocytosis—Epirubicin—breast cancer	0.000232	0.000236	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—breast cancer	0.000231	0.000235	CcSEcCtD
Tobramycin—Pruritus—Fluorouracil—breast cancer	0.00023	0.000235	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—breast cancer	0.00023	0.000235	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—breast cancer	0.00023	0.000234	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—breast cancer	0.00023	0.000234	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—breast cancer	0.00023	0.000234	CcSEcCtD
Tobramycin—Confusional state—Capecitabine—breast cancer	0.00023	0.000234	CcSEcCtD
Tobramycin—Feeling abnormal—Paclitaxel—breast cancer	0.000229	0.000233	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—breast cancer	0.000228	0.000233	CcSEcCtD
Tobramycin—Gastrointestinal pain—Paclitaxel—breast cancer	0.000227	0.000231	CcSEcCtD
Tobramycin—Diarrhoea—Gemcitabine—breast cancer	0.000227	0.000231	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—breast cancer	0.000226	0.00023	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—breast cancer	0.000226	0.00023	CcSEcCtD
Tobramycin—Dizziness—Irinotecan—breast cancer	0.000225	0.000229	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—breast cancer	0.000224	0.000228	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—breast cancer	0.000224	0.000228	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—breast cancer	0.000224	0.000228	CcSEcCtD
Tobramycin—Nervous system disorder—Capecitabine—breast cancer	0.000223	0.000227	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—breast cancer	0.000223	0.000227	CcSEcCtD
Tobramycin—Diarrhoea—Fluorouracil—breast cancer	0.000223	0.000227	CcSEcCtD
Tobramycin—Thrombocytopenia—Capecitabine—breast cancer	0.000223	0.000227	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—breast cancer	0.000222	0.000227	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—breast cancer	0.000222	0.000226	CcSEcCtD
Tobramycin—Skin disorder—Capecitabine—breast cancer	0.000221	0.000225	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—breast cancer	0.00022	0.000225	CcSEcCtD
Tobramycin—Urticaria—Paclitaxel—breast cancer	0.00022	0.000224	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—breast cancer	0.000219	0.000223	CcSEcCtD
Tobramycin—Abdominal pain—Paclitaxel—breast cancer	0.000219	0.000223	CcSEcCtD
Tobramycin—Body temperature increased—Paclitaxel—breast cancer	0.000219	0.000223	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—breast cancer	0.000219	0.000223	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—breast cancer	0.000217	0.000221	CcSEcCtD
Tobramycin—Anorexia—Capecitabine—breast cancer	0.000217	0.000221	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—breast cancer	0.000216	0.00022	CcSEcCtD
Tobramycin—Vomiting—Irinotecan—breast cancer	0.000216	0.00022	CcSEcCtD
Tobramycin—Vomiting—Mitoxantrone—breast cancer	0.000216	0.00022	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—breast cancer	0.000216	0.00022	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—breast cancer	0.000215	0.000219	CcSEcCtD
Tobramycin—Dizziness—Fluorouracil—breast cancer	0.000215	0.000219	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—breast cancer	0.000215	0.000219	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—breast cancer	0.000215	0.000219	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—breast cancer	0.000215	0.000219	CcSEcCtD
Tobramycin—Rash—Irinotecan—breast cancer	0.000214	0.000218	CcSEcCtD
Tobramycin—Rash—Mitoxantrone—breast cancer	0.000214	0.000218	CcSEcCtD
Tobramycin—Dermatitis—Irinotecan—breast cancer	0.000214	0.000218	CcSEcCtD
Tobramycin—Dermatitis—Mitoxantrone—breast cancer	0.000214	0.000218	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000214	0.000218	CcSEcCtD
Tobramycin—Headache—Mitoxantrone—breast cancer	0.000213	0.000217	CcSEcCtD
Tobramycin—Headache—Irinotecan—breast cancer	0.000213	0.000217	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—breast cancer	0.000211	0.000215	CcSEcCtD
Tobramycin—Vomiting—Gemcitabine—breast cancer	0.000211	0.000215	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—breast cancer	0.00021	0.000214	CcSEcCtD
Tobramycin—Rash—Gemcitabine—breast cancer	0.000209	0.000213	CcSEcCtD
Tobramycin—Dermatitis—Gemcitabine—breast cancer	0.000209	0.000213	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—breast cancer	0.000209	0.000213	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—breast cancer	0.000208	0.000212	CcSEcCtD
Tobramycin—Erythema—Methotrexate—breast cancer	0.000208	0.000212	CcSEcCtD
Tobramycin—Headache—Gemcitabine—breast cancer	0.000208	0.000211	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000207	0.000211	CcSEcCtD
Tobramycin—Vomiting—Fluorouracil—breast cancer	0.000207	0.000211	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—breast cancer	0.000207	0.000211	CcSEcCtD
Tobramycin—Rash—Fluorouracil—breast cancer	0.000205	0.000209	CcSEcCtD
Tobramycin—Dermatitis—Fluorouracil—breast cancer	0.000205	0.000209	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—breast cancer	0.000205	0.000209	CcSEcCtD
Tobramycin—Paraesthesia—Capecitabine—breast cancer	0.000204	0.000208	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—breast cancer	0.000204	0.000208	CcSEcCtD
Tobramycin—Hypersensitivity—Paclitaxel—breast cancer	0.000204	0.000208	CcSEcCtD
Tobramycin—Headache—Fluorouracil—breast cancer	0.000204	0.000208	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—breast cancer	0.000204	0.000208	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—breast cancer	0.000203	0.000207	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000203	0.000207	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—breast cancer	0.000203	0.000207	CcSEcCtD
Tobramycin—Dyspnoea—Capecitabine—breast cancer	0.000203	0.000207	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—breast cancer	0.000203	0.000206	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—breast cancer	0.000202	0.000206	CcSEcCtD
Tobramycin—Nausea—Mitoxantrone—breast cancer	0.000202	0.000206	CcSEcCtD
Tobramycin—Nausea—Irinotecan—breast cancer	0.000202	0.000206	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—breast cancer	0.000202	0.000205	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—breast cancer	0.000201	0.000205	CcSEcCtD
Tobramycin—Pain—Docetaxel—breast cancer	0.000201	0.000205	CcSEcCtD
Tobramycin—Back pain—Methotrexate—breast cancer	0.000201	0.000205	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—breast cancer	0.000199	0.000203	CcSEcCtD
Tobramycin—Asthenia—Paclitaxel—breast cancer	0.000199	0.000203	CcSEcCtD
Tobramycin—Decreased appetite—Capecitabine—breast cancer	0.000198	0.000202	CcSEcCtD
Tobramycin—Nausea—Gemcitabine—breast cancer	0.000197	0.0002	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000197	0.0002	CcSEcCtD
Tobramycin—Pruritus—Paclitaxel—breast cancer	0.000196	0.0002	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—breast cancer	0.000196	0.000199	CcSEcCtD
Tobramycin—Pain—Capecitabine—breast cancer	0.000195	0.000198	CcSEcCtD
Tobramycin—Erythema—Epirubicin—breast cancer	0.000194	0.000198	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—breast cancer	0.000194	0.000197	CcSEcCtD
Tobramycin—Nausea—Fluorouracil—breast cancer	0.000194	0.000197	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—breast cancer	0.000193	0.000197	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—breast cancer	0.000193	0.000196	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—breast cancer	0.000193	0.000196	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—breast cancer	0.000192	0.000196	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—breast cancer	0.000192	0.000196	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—breast cancer	0.00019	0.000194	CcSEcCtD
Tobramycin—Diarrhoea—Paclitaxel—breast cancer	0.00019	0.000193	CcSEcCtD
Tobramycin—Back pain—Epirubicin—breast cancer	0.000188	0.000191	CcSEcCtD
Tobramycin—Feeling abnormal—Capecitabine—breast cancer	0.000188	0.000191	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—breast cancer	0.000187	0.000191	CcSEcCtD
Tobramycin—Malaise—Methotrexate—breast cancer	0.000187	0.000191	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—breast cancer	0.000187	0.00019	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—breast cancer	0.000187	0.00019	CcSEcCtD
Tobramycin—Gastrointestinal pain—Capecitabine—breast cancer	0.000186	0.00019	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—breast cancer	0.000186	0.00019	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—breast cancer	0.000186	0.000189	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—breast cancer	0.000186	0.000189	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—breast cancer	0.000186	0.000189	CcSEcCtD
Tobramycin—Dizziness—Paclitaxel—breast cancer	0.000183	0.000187	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—breast cancer	0.000183	0.000187	CcSEcCtD
Tobramycin—Cough—Methotrexate—breast cancer	0.000181	0.000185	CcSEcCtD
Tobramycin—Urticaria—Capecitabine—breast cancer	0.000181	0.000184	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—breast cancer	0.00018	0.000184	CcSEcCtD
Tobramycin—Abdominal pain—Capecitabine—breast cancer	0.00018	0.000183	CcSEcCtD
Tobramycin—Body temperature increased—Capecitabine—breast cancer	0.00018	0.000183	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—breast cancer	0.00018	0.000183	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—breast cancer	0.00018	0.000183	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—breast cancer	0.000177	0.00018	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—breast cancer	0.000177	0.00018	CcSEcCtD
Tobramycin—Vomiting—Paclitaxel—breast cancer	0.000176	0.00018	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—breast cancer	0.000176	0.000179	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000176	0.000179	CcSEcCtD
Tobramycin—Malaise—Epirubicin—breast cancer	0.000175	0.000179	CcSEcCtD
Tobramycin—Rash—Paclitaxel—breast cancer	0.000175	0.000178	CcSEcCtD
Tobramycin—Dermatitis—Paclitaxel—breast cancer	0.000175	0.000178	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—breast cancer	0.000175	0.000178	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—breast cancer	0.000175	0.000178	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—breast cancer	0.000174	0.000177	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—breast cancer	0.000174	0.000177	CcSEcCtD
Tobramycin—Headache—Paclitaxel—breast cancer	0.000174	0.000177	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—breast cancer	0.000173	0.000176	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—breast cancer	0.000171	0.000174	CcSEcCtD
Tobramycin—Cough—Epirubicin—breast cancer	0.00017	0.000173	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—breast cancer	0.000169	0.000173	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—breast cancer	0.000169	0.000173	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—breast cancer	0.000169	0.000172	CcSEcCtD
Tobramycin—Hypersensitivity—Capecitabine—breast cancer	0.000168	0.000171	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—breast cancer	0.000167	0.00017	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—breast cancer	0.000166	0.000169	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—breast cancer	0.000166	0.000169	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—breast cancer	0.000166	0.000169	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—breast cancer	0.000166	0.000169	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—breast cancer	0.000165	0.000169	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—breast cancer	0.000165	0.000169	CcSEcCtD
Tobramycin—Nausea—Paclitaxel—breast cancer	0.000165	0.000168	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—breast cancer	0.000165	0.000168	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000164	0.000167	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—breast cancer	0.000163	0.000167	CcSEcCtD
Tobramycin—Asthenia—Capecitabine—breast cancer	0.000163	0.000166	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—breast cancer	0.000162	0.000165	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—breast cancer	0.000162	0.000165	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—breast cancer	0.000162	0.000165	CcSEcCtD
Tobramycin—Pruritus—Capecitabine—breast cancer	0.000161	0.000164	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—breast cancer	0.000161	0.000164	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—breast cancer	0.000161	0.000164	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—breast cancer	0.00016	0.000163	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—breast cancer	0.000159	0.000162	CcSEcCtD
Tobramycin—Cough—Doxorubicin—breast cancer	0.000157	0.00016	CcSEcCtD
Tobramycin—Diarrhoea—Capecitabine—breast cancer	0.000156	0.000159	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—breast cancer	0.000156	0.000158	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—breast cancer	0.000155	0.000158	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—breast cancer	0.000155	0.000158	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000154	0.000157	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—breast cancer	0.000154	0.000157	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—breast cancer	0.000153	0.000156	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—breast cancer	0.000153	0.000156	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—breast cancer	0.000152	0.000155	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000152	0.000155	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—breast cancer	0.000151	0.000154	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—breast cancer	0.000151	0.000154	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—breast cancer	0.000151	0.000154	CcSEcCtD
Tobramycin—Dizziness—Capecitabine—breast cancer	0.000151	0.000153	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—breast cancer	0.000149	0.000152	CcSEcCtD
Tobramycin—Rash—Docetaxel—breast cancer	0.000148	0.000151	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—breast cancer	0.000148	0.000151	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—breast cancer	0.000148	0.000151	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—breast cancer	0.000147	0.00015	CcSEcCtD
Tobramycin—Headache—Docetaxel—breast cancer	0.000147	0.00015	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—breast cancer	0.000147	0.000149	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000146	0.000149	CcSEcCtD
Tobramycin—Pain—Methotrexate—breast cancer	0.000145	0.000148	CcSEcCtD
Tobramycin—Vomiting—Capecitabine—breast cancer	0.000145	0.000147	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000144	0.000147	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—breast cancer	0.000144	0.000147	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—breast cancer	0.000144	0.000146	CcSEcCtD
Tobramycin—Rash—Capecitabine—breast cancer	0.000144	0.000146	CcSEcCtD
Tobramycin—Dermatitis—Capecitabine—breast cancer	0.000143	0.000146	CcSEcCtD
Tobramycin—Headache—Capecitabine—breast cancer	0.000143	0.000145	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—breast cancer	0.000143	0.000145	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—breast cancer	0.000142	0.000145	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—breast cancer	0.000141	0.000144	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—breast cancer	0.00014	0.000142	CcSEcCtD
Tobramycin—Nausea—Docetaxel—breast cancer	0.00014	0.000142	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—breast cancer	0.00014	0.000142	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—breast cancer	0.000139	0.000141	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—breast cancer	0.000138	0.00014	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000137	0.000139	CcSEcCtD
Tobramycin—Pain—Epirubicin—breast cancer	0.000136	0.000138	CcSEcCtD
Tobramycin—Nausea—Capecitabine—breast cancer	0.000135	0.000138	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—breast cancer	0.000135	0.000137	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—breast cancer	0.000134	0.000136	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—breast cancer	0.000134	0.000136	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000134	0.000136	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—breast cancer	0.000132	0.000134	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—breast cancer	0.000131	0.000133	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—breast cancer	0.000131	0.000133	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—breast cancer	0.00013	0.000132	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—breast cancer	0.000128	0.00013	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000127	0.000129	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—breast cancer	0.000126	0.000128	CcSEcCtD
Tobramycin—Pain—Doxorubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—breast cancer	0.000125	0.000128	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—breast cancer	0.000125	0.000127	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—breast cancer	0.000122	0.000124	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—breast cancer	0.000121	0.000123	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—breast cancer	0.00012	0.000122	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—breast cancer	0.00012	0.000122	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—breast cancer	0.000117	0.000119	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—breast cancer	0.000117	0.000119	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—breast cancer	0.000116	0.000118	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—breast cancer	0.000116	0.000118	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—breast cancer	0.000116	0.000118	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—breast cancer	0.000114	0.000116	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—breast cancer	0.000112	0.000114	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—breast cancer	0.000112	0.000114	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—breast cancer	0.000109	0.000111	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—breast cancer	0.000108	0.00011	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—breast cancer	0.000108	0.00011	CcSEcCtD
Tobramycin—Rash—Methotrexate—breast cancer	0.000107	0.000109	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—breast cancer	0.000107	0.000109	CcSEcCtD
Tobramycin—Headache—Methotrexate—breast cancer	0.000106	0.000108	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—breast cancer	0.000105	0.000107	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—breast cancer	0.000105	0.000107	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—breast cancer	0.000104	0.000106	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—breast cancer	0.000101	0.000103	CcSEcCtD
Tobramycin—Nausea—Methotrexate—breast cancer	0.000101	0.000103	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—breast cancer	0.0001	0.000102	CcSEcCtD
Tobramycin—Rash—Epirubicin—breast cancer	0.0001	0.000102	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—breast cancer	9.99e-05	0.000102	CcSEcCtD
Tobramycin—Headache—Epirubicin—breast cancer	9.94e-05	0.000101	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—breast cancer	9.7e-05	9.88e-05	CcSEcCtD
Tobramycin—Nausea—Epirubicin—breast cancer	9.42e-05	9.6e-05	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—breast cancer	9.33e-05	9.5e-05	CcSEcCtD
Tobramycin—Rash—Doxorubicin—breast cancer	9.25e-05	9.43e-05	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—breast cancer	9.24e-05	9.42e-05	CcSEcCtD
Tobramycin—Headache—Doxorubicin—breast cancer	9.19e-05	9.36e-05	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—breast cancer	8.72e-05	8.88e-05	CcSEcCtD
